title: Use of a biomarker in exposure-response analysis to support dose selection for fingolimod.
abstract: Fingolimod 0.5 mg q.d. (once daily) has been approved for the treatment of patients with relapsing and remitting forms of multiple sclerosis (RRMS). Fingolimod at two doses (0.5 and 1.25 mg) showed superior effectiveness in the frequency of relapse with little difference between the two dose groups. At the same time, fingolimod manifests a number of dose-dependent adverse events. Given the safety concerns and similar effect size at both dose groups, it was reasonable to raise the question whether doses even lower than 0.5 mg would produce sufficient effectiveness. Therefore, our analysis focused on estimating the effect size of the primary endpoint at doses lower than 0.5 mg via exposure-response analysis. Specifically, we aim to show how biomarker data can be used as a bridge in exposure-response analysis to estimate the clinical endpoint response at certain doses when the direct relationship between exposure and the clinical endpoint can not be quantified reliably.CPT: Pharmacometrics & Systems Pharmacology (2013) 2, e67; doi:10.1038/psp.2013.44; published online 21 August 2013.
authors: Division of Pharmacometrics, Office of Clinical Pharmacology, Food and Drug Administration, Silver Spring, Maryland, USA.
authors: J-Y
authors: JY
authors: Lee
authors: Y
authors: Y
authors: Wang
references: AAPS J. 2005 Oct 07;7(3):E503-12
references: 16353928
references: Clin Pharmacol Ther. 2007 Feb;81(2):213-21
references: 17259946
references: N Engl J Med. 2010 Feb 4;362(5):402-15
references: 20089954
references: FEBS Lett. 2003 Nov 6;554(1-2):189-93
references: 14596938
references: Clin Pharmacokinet. 2011 Oct;50(10):627-35
references: 21895036
references: Arch Ophthalmol. 2008 Jan;126(1):140-1
references: 18195237
references: J Biol Chem. 2009 Feb 27;284(9):5467-77
references: 19119142
references: Nephrol Dial Transplant. 2007 Aug;22(8):2354-8
references: 17526535
references: J Biol Chem. 2003 Nov 28;278(48):47408-15
references: 13129923